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literature, Anti-D was selected over IVIG as the preferred agent
at Staten Island University Hospital. The objectives of this study
were to investigate how much IVIG was spared after implemen-
tation of this decision and determine the cost savings realized
when Anti-D is used in place of IVIG. METHODS: Literature
supporting the utilization of Anti-D in treatment of ITP was
presented by each of the key clinical faculty. The oncology phar-
macist screened and veriﬁed all IVIG orders for ITP patients.
Substitution with Anti-D was made for all Rh+ and non-
splenectomized patients. The quantity of IVIG spared was calcu-
lated by subtracting the amount dispensed before and after
implementation of the program. Savings realized were calculated
by determining the cost of a treatment course with IVIG and with
Anti-D for a 80 kg patient. RESULTS: A total of 904 and 130 g
of IVIG were administered during the ﬁrst and the second half
of 2006, respectively. Similarly, 220,000 and 376,000 units of
Anti-D were used during the same time periods. A treatment
course with IVIG (at 1 g/kg/day for two days) costs $8960
whereas a treatment course of Anti-D costs $4200 (at 75 ìg/kg).
Since the treatment of a 80 kg patient would require 160 g of
IVIG, the 774 g spared represent the amount necessary to treat
5 patients with IVIG. The sparing of 774 g of IVIG therefore
helped save $23,800. Also, 3 other courses were done with
Anti-D instead of IVIG yielding $14,280 in additional savings.
CONCLUSION: In 2006, the implementation of a therapeutic
substitution program at Staten Island University Hospital
making Anti-D the preferred agent over IVIG in the treatment of
ITP helped spare 774 grams of IVIG and saved $38,080.
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OBJECTIVE: Heparin-induced thrombocytopenia (HIT) is an
important adverse reaction associated with heparin utilization.
No previous studies have assessed the cost of suspected HIT or
examined HIT from a Canadian perspective. Therefore, the
objective of our study was to quantify the direct medical costs
associated with suspected and conﬁrmed HIT from a Canadian
hospital perspective. METHODS: A cost of illness analysis was
conducted on a population of consecutive patients with sus-
pected HIT during 2005. Suspected HIT was deﬁned by the
performance of a HIT enzyme-linked immunosorbent assay
(ELISA). Conﬁrmed HIT was deﬁned by one the following: 1)
positive serotonin release assay (SRA), 2) positive HIT ELISA
plus high clinical probability for HIT, or 3) strongly positive
HIT ELISA (optical density  1.0). Negative HIT was deﬁned
as a negative HIT ELISA or SRA result. Resource utilization
variables included: 1) HIT-safe anticoagulant use, 2) laboratory
tests, 3) diagnostic and surgical procedures, and 4) length of
stay (LOS) attributed to HIT. The average cost (2007 CAN$)
per case of conﬁrmed HIT, conﬁrmed HIT with thrombosis
(HITT), and negative HIT was calculated. Cost data was
obtained from hospital and provincial sources. RESULTS:
There were 110 suspected HIT cases (56 males: 54 females) in
2005. Two patients were excluded because their HIT status
could not be determined. Average LOS was 36  42 (range
3–244) days. There were 88 negative HIT cases, 8 with con-
ﬁrmed HIT, and 12 with conﬁrmed HITT. Patients with con-
ﬁrmed HITT incurred substantially greater average costs
($25,696, range $357–$145,217) than those with conﬁrmed
HIT ($3846, range $38–$14,258). The average cost of a nega-
tive HIT case was $115 (range $38–$4119). CONCLUSION:
This is the ﬁrst study to identify the costs associated with con-
ﬁrmed HIT, conﬁrmed HITT, and negative HIT. Suspected HIT
increases the costs of hospital care.
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OBJECTIVE: To examine literature published during the past ten
years describing the impact of obesity and obesity-related disease
on direct and indirect costs in Australia, Canada, France,
Germany, Italy, Spain, Sweden, the UK, and the US. METHODS:
A review of the medical literature published from 1997 to 2007
was conducted, including MEDLINE, EMBASE, Current
Contents Connect, and International Pharmaceutical Abstracts
databases; ISPOR abstracts; and data published by relevant gov-
ernmental agencies. RESULTS: A substantial portion of direct
costs related to obesity derive from treating comorbidities asso-
ciated with the condition (e.g., type 2 diabetes, cardiovascular
disease). Indirect costs, including those associated with reduced
work productivity, increased absenteeism, and premature death,
are signiﬁcant, with the majority arising from comorbid condi-
tions. Direct costs were greater for obese patients than for
normal-weight patients; morbid obesity was associated with dra-
matic cost increases. Estimates of direct costs as a percentage of
national health care expenditures were 5.7% for the US, and
ranged from 2% to 2.6% for Australia, Canada, Sweden, and the
UK. No estimates of indirect costs as a percentage of national
health care costs were identiﬁed. No studies involving direct or
indirect cost data collected since 1995 were identiﬁed for France,
Italy, or Spain. CONCLUSION: Obesity has a substantial eco-
nomic impact because of its high prevalence, association with
multiple chronic diseases, and increased levels of disability and
absenteeism. The lack of recent direct or indirect cost estimates in
several countries highlights the need for further work to describe
the global economic burden of obesity.
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OBJECTIVE: Conduct a systematic review of low back pain cost
of illness studies. METHODS: Medline was searched to uncover
studies about the direct or indirect costs of low back pain pub-
lished in English from 1997 to 2007. Data extracted for each
eligible study included study design, population, deﬁnition of low
back pain, methodology for estimating costs, year of data, and
estimates of direct, indirect, or total costs. RESULTS: The search
yielded 147 studies; 27 were deemed relevant. The studies
reported on data from Australia, Belgium, Japan, Korea, The
Netherlands, Sweden, the UK, and the US. Nine studies estimated
direct costs only, 9 indirect costs only, and 9 both direct and
indirect costs, from a societal (n = 18) or private insurer (n = 9)
perspective. Methodology used to derive both direct and indirect
cost estimates differed markedly among the studies. Among
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studies providing a breakdown on direct costs, the largest pro-
portion of direct medical costs for low back pain was spent on
physical therapy (17%) and inpatient services (17%), followed
by pharmacy (13%) and primary care (13%). Among studies
providing estimates of total costs, indirect costs due to lost work
productivity represented a majority of overall costs associated
with low back pain. Three studies reported that estimates with
the friction period approach were 56% lower than with the
human capital approach. CONCLUSION: Estimates of the eco-
nomic costs in different countries vary greatly depending on
study methodology but by any standards must be considered a
substantial burden on society. This review did not identify any
studies estimating the total costs of low back pain in the US from
a societal perspective. Such studies may be helpful in determining
appropriate allocation of health care resources devoted to this
condition.
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OBJECTIVE: This study quantiﬁes the direct and indirect costs
of obesity within a cohort of commercially-insured employees
between 2003–2005. METHODS: A database of health plan
claims, self-reported health risk assessments (HRAs), and pro-
ductivity data (Thomson MarketScan) from 2003–2005 was
used to identify individuals for analysis. The study cohort
included individuals reporting a valid body mass index (BMI)
value on an HRA and 12 months of continuous eligibility.
Patients were divided into ﬁve groups according to the WHO
classiﬁcation of BMI: severely obese (BMI  35), obese
(30  BMI < 35), overweight (25  BMI < 30), normal weight
(18.5  BMI < 25), and underweight (BMI < 18.5). Mean direct
medical costs and the costs associated with employee absence
were calculated for each BMI group. Two-part regression models
were used to estimate the incremental direct and indirect costs,
conditional upon expenditure, associated with elevated BMI.
RESULTS: Of 88,984 employees (45% female, mean
age = 42.3), 9.9% were severely obese, 16.7% obese, 38.5%
overweight, 34.0% normal weight, and <1% were underweight.
With the exception of the underweight BMI group, univariate
analysis reveals a graded pattern of expenditures for emergency
room and outpatient pharmacy. As BMI increases, expenditures
for these services increase. Further, compared to those with a
normal BMI, the obese and severely obese have higher costs for
inpatient hospital and outpatient visits and services. Regression-
adjusted incremental direct medical costs associated with being
overweight, obese, and severely obese were estimated to be
$147.11, $712.34, and $1977.43, respectively. Regression-
adjusted incremental indirect costs due to paid time off associ-
ated with being overweight, obese, and severely obese were
estimated at $1403.81 $1511.24, and $1414.09, respectively.
CONCLUSION: Overall health care costs were higher for
workers who were obese or severely obese than for those of
normal weight or who were overweight. Indirect costs incurred
from paid time off were higher for workers in all categories of
elevated BMI relative to those of normal weight.
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OBJECTIVE: To evaluate the cost and outcomes of a weight
control program in a regional hospital at southern Taiwan.
METHODS: A total of 249 subjects with BMI over 24 were
recruited from August 2003 to June 2004. Monthly courses
providing nutritional consultation and exercise instructions for
ﬁtness were offered in three sessions per week with class size less
than 25 members. Content of the course includes Physical Fitness
exercise coaching, healthy diet and prescription of medication for
weight control, and consultation for behavior change. Statistic
analysis of data was performed with SAS software. RESULTS:
The mean age of the 249 subjects is 38.39(12.36) years old,
with 202(81.1%) female and 47(19.9%) male. The mean of BMI
is 29.98(5.10) kg/m2, mean of body fat percentage is
38.88(7.54). Cost for the weight control clinic service includes
pharmaceutical, special formula of diet, education for healthy
eating, aerobic exercise coaching, personnel and administrative
expense. Analysis revealed the total cost for each person-visit of
a subject is 4426 NT dollars, with 5016 NT dollars per visit for
subjects accepting additional ﬁtness training. The weight
decrease in average is 4.52 + 7.52 kg, and the length of follow up
in average is 68.97 + 54.36 day. In total there is 610.3 kg
of weight reduction during the period of the project and the
average cost for each kg weight reduction is 2212  516 NT
dollars. Statistic analysis with Mixed Model revealed that after
adjusted by gender and age, the BMI of subjects will decrease by
an estimate of 0.03757 with the increase of each day. CONCLU-
SION: The strategy of combining medication prescription, diet
consultation and exercise coaching to reduce body weight in the
beginning of the course is an effective enforcement to motivate
the subject to establish the habit of regular exercise.
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OBJECTIVE: Among hospitalized patients, hyponatremia
(serum sodium <136 mmol/L) is a common problem associated
with increased mortality, morbidity, and length-of-stay (LOS)
in clinical trials and other studies. However, studies relating
hyponatremia to costs, controlling for the other factors, are
limited. The purpose of this study was to examine the relation-
ships between hyponatremia and hospital mortality, LOS, and
costs in naturalistic settings with large sample size. METHODS:
We conducted a retrospective analysis of nationally projected
adult acute care inpatient discharges from January 2003–June
2006, in the Premier Perspective clinical and economic database
of >37 million actual discharges from ~600 US hospitals. We
compared patients with hyponatremia (ICD-9-CM diagnosis
code 276.1x) during hospitalization to a comparably sized
random sample without hyponatremia, matched on age, gender,
and comorbidities. Descriptive analyses including APR-DRG
severity-of-illness, mortality, LOS, and costs. Chi-squared tests
were used for mortality comparisons and Kruskal-Wallis for LOS
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